[go: up one dir, main page]

ATE395596T1 - Diagnostisches panel ibd-first chek fur entzundliche darmerkrankung (ibd) und reizkolon - Google Patents

Diagnostisches panel ibd-first chek fur entzundliche darmerkrankung (ibd) und reizkolon

Info

Publication number
ATE395596T1
ATE395596T1 AT03776577T AT03776577T ATE395596T1 AT E395596 T1 ATE395596 T1 AT E395596T1 AT 03776577 T AT03776577 T AT 03776577T AT 03776577 T AT03776577 T AT 03776577T AT E395596 T1 ATE395596 T1 AT E395596T1
Authority
AT
Austria
Prior art keywords
ibd
disease
ibs
crohn
bowel disease
Prior art date
Application number
AT03776577T
Other languages
English (en)
Inventor
James Boone
David Lyerly
Tracy Wilkins
Original Assignee
Techlab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Techlab Inc filed Critical Techlab Inc
Application granted granted Critical
Publication of ATE395596T1 publication Critical patent/ATE395596T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/395—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Saccharomyces
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03776577T 2002-10-25 2003-10-24 Diagnostisches panel ibd-first chek fur entzundliche darmerkrankung (ibd) und reizkolon ATE395596T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42139502P 2002-10-25 2002-10-25

Publications (1)

Publication Number Publication Date
ATE395596T1 true ATE395596T1 (de) 2008-05-15

Family

ID=32176708

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03776577T ATE395596T1 (de) 2002-10-25 2003-10-24 Diagnostisches panel ibd-first chek fur entzundliche darmerkrankung (ibd) und reizkolon

Country Status (8)

Country Link
US (1) US7785818B2 (de)
EP (1) EP1554580B1 (de)
AT (1) ATE395596T1 (de)
AU (1) AU2003284187B2 (de)
CA (1) CA2502976C (de)
DE (1) DE60321027D1 (de)
ES (1) ES2306902T3 (de)
WO (1) WO2004037073A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004022713A2 (en) * 2002-09-05 2004-03-18 Techlab, Inc. Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca)
CA2502976C (en) * 2002-10-25 2012-05-22 Techlab, Inc. Inflammatory bowel disease and irritable bowel syndrome ibd-first chek diagnostic panel
US20060154276A1 (en) 2004-05-13 2006-07-13 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
US7759079B2 (en) 2004-05-13 2010-07-20 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
US7873479B2 (en) 2005-12-01 2011-01-18 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
US8685741B1 (en) 2007-03-07 2014-04-01 Nestec S.A. Methods for diagnosing irritable bowel syndrome
US20100129838A1 (en) 2008-11-11 2010-05-27 Prometheus Laboratories Inc. Methods for prediction of inflammatory bowel disease (ibd) using serologic markers
CN102341705B (zh) * 2009-03-05 2015-08-19 味之素株式会社 克罗恩氏病诊断试剂
WO2010120814A1 (en) * 2009-04-14 2010-10-21 Prometheus Laboratories Inc. Inflammatory bowel disease prognostics
EP2778685B1 (de) 2009-06-25 2017-04-26 Nestec S.A. Verfahren zur diagnostizierung des reizdarmsyndroms
WO2011060098A1 (en) 2009-11-10 2011-05-19 Prometheus Laboratories Inc. Methods for predicting post-surgery risk associated with ileal pouch-anal anastomosis
JP5857503B2 (ja) * 2010-07-29 2016-02-10 小野薬品工業株式会社 ストレス性疾患のバイオマーカー
CN103906760B (zh) 2010-11-26 2017-02-22 赢创罗姆有限公司 用作抗原掩蔽剂的人乳铁蛋白衍生肽
KR20140008397A (ko) 2011-02-17 2014-01-21 네스텍 소시에테아노님 항-ＴＮＦα 약물에 대한 자가항체 검출을 위한 검정법
CA2839792A1 (en) 2011-05-10 2012-11-15 Nestec S.A. Methods of disease activity profiling for personalized therapy management
AU2012325798B2 (en) 2011-10-21 2015-11-26 Société des Produits Nestlé S.A. Methods for improving inflammatory bowel disease diagnosis
WO2013132338A2 (en) 2012-03-06 2013-09-12 Calpro As Competitive immunoassay for calprotectin
WO2013132347A2 (en) 2012-03-06 2013-09-12 Calpro As Improved elisa immunoassay for calprotectin
CN103575903B (zh) * 2012-08-07 2016-01-20 中国检验检疫科学研究院 一种人乳铁蛋白夹心elisa检测试剂盒及其应用
EP3094973B1 (de) 2013-11-07 2020-07-29 Diagnodus Limited Biomarker
US10513552B2 (en) * 2014-06-20 2019-12-24 Immunimed Inc. Use of polyclonal antibodies against clostridium difficile for treatment of inflammatory bowel disease
CN104991067A (zh) * 2014-08-20 2015-10-21 苏州和锐医药科技有限公司 一种抗asca抗体测试试纸的制备方法及应用
PL3171174T3 (pl) * 2015-11-20 2018-04-30 Geroa Diagnostics, S.L Laktoferryna do zastosowania w diagnostyce lub prognozowaniu choroby Alzheimera
RU2668496C2 (ru) * 2017-03-16 2018-10-01 Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр Департамента здравоохранения города Москвы Способ диагностики тяжести течения синдрома раздраженного кишечника
CA3135012A1 (en) * 2017-05-31 2018-12-06 Anjali Jain Methods for assessing mucosal healing in crohn's disease patients
CN111896749A (zh) * 2020-08-07 2020-11-06 杭州都林生物科技有限公司 牛乳铁蛋白双抗体夹心胶体金免疫层析试纸条、制备方法、试剂盒和检测方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124252A (en) * 1989-11-28 1992-06-23 University Of Virginia Alumni Patents Foundation In vitro test for fecal leukocytes
WO1992016843A1 (en) 1991-03-22 1992-10-01 Guerrant Richard L In vitro test for leukocytes in body fluids
US6008327A (en) 1992-03-13 1999-12-28 Akzo Nobel, N.V. Peptides and nucleic acid sequences related to the Epstein Barr virus
US5359038A (en) 1992-07-14 1994-10-25 Eloy Padron Method for isolating immunoglobulin compounds in the feces
US5552292A (en) * 1993-01-18 1996-09-03 Ikagaku Co., Ltd. Method of screening for colorectal cancer
ES2148251T3 (es) 1993-03-10 2000-10-16 Cedars Sinai Medical Center Metodos para detectar selectivamente anticuerpos anticitoplasma de neutrofilos perinucleares de la colitis ulcerosa o colangitis esclerosante primaria.
US5455160A (en) 1993-05-27 1995-10-03 Fagerhol; Magne K. Diagnostic test and kit for disease or disorders in the digestive system
DE4402065A1 (de) * 1994-01-25 1995-09-07 Behringwerke Ag Saccharomyces-spezifische Antigene und Antikörper, deren Herstellung und Verwendung
US5681699A (en) 1994-02-11 1997-10-28 Cedars-Sinai Medical Center Methods of diagnosing ulcerative colitis and Crohn's disease
US5691151A (en) 1994-10-07 1997-11-25 Regents Of University Of California Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US5932429A (en) * 1996-04-12 1999-08-03 Cedars-Sinai Medical Center Methods of diagnosing clinical subtypes of crohn's disease
US6033864A (en) 1996-04-12 2000-03-07 The Regents Of The University Of California Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
US6074835A (en) 1996-04-12 2000-06-13 Regents Of The Univ. Of California Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone H1
US5874233A (en) 1996-04-12 1999-02-23 Cedars-Sinai Medical Center Methods of diagnosing a clinical subtype of Crohn's disease with features of ulcerative colitis
US5916748A (en) 1996-04-12 1999-06-29 Cedars-Sinai Medical Center Method of diagnosing a clinical subtype of crohn's disease with features of ulcerative colitis
US6174664B1 (en) 1997-02-05 2001-01-16 University Of Pittsburgh Screening method for inflammatory diseases using neutrophil defensins and lactoferrin
US5968741A (en) 1997-04-11 1999-10-19 Cedars-Sinai Medical Center Methods of diagnosing a medically resistant clinical subtype of ulcerative colitis
US6218129B1 (en) * 1998-05-15 2001-04-17 Prometheus Laboratories, Inc. Inflammatory bowel disease first step assay system
US6727073B1 (en) * 1999-11-19 2004-04-27 Binax, Inc. Method for detecting enteric disease
US6667160B2 (en) * 2000-03-15 2003-12-23 Kenneth D. Fine Method for diagnosing immunologic food sensitivity
ES2325059T3 (es) * 2000-11-14 2009-08-25 Techlab, Inc. Metodo para diferenciar el sindrome del intestino irritable de la enfermedad inflamatoria intestinal (ibd) y para seguir personas con ibd usando la lactoferrina endogena total como marcador.
US6818181B2 (en) 2001-03-15 2004-11-16 Savyon Diagnostics Ltd. Kit and method for detecting food allergies
US6872540B2 (en) * 2001-10-26 2005-03-29 Techlab, Inc. Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae
WO2004022713A2 (en) * 2002-09-05 2004-03-18 Techlab, Inc. Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca)
CA2502976C (en) * 2002-10-25 2012-05-22 Techlab, Inc. Inflammatory bowel disease and irritable bowel syndrome ibd-first chek diagnostic panel
US7759079B2 (en) * 2004-05-13 2010-07-20 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome

Also Published As

Publication number Publication date
AU2003284187B2 (en) 2009-10-01
EP1554580A4 (de) 2006-05-31
EP1554580B1 (de) 2008-05-14
WO2004037073A3 (en) 2004-07-01
CA2502976A1 (en) 2004-05-06
DE60321027D1 (de) 2008-06-26
CA2502976C (en) 2012-05-22
WO2004037073A2 (en) 2004-05-06
US20040137536A1 (en) 2004-07-15
ES2306902T3 (es) 2008-11-16
AU2003284187A1 (en) 2004-05-13
US7785818B2 (en) 2010-08-31
EP1554580A2 (de) 2005-07-20

Similar Documents

Publication Publication Date Title
ATE395596T1 (de) Diagnostisches panel ibd-first chek fur entzundliche darmerkrankung (ibd) und reizkolon
Kane et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation
Jhung et al. Toxinotype V Clostridium difficile in humans and food animals
CN105579852B (zh) 用于诊断肠易激惹综合征的途径特异性标志物
Lucero et al. Diagnosis of human brucellosis caused by Brucella canis
Nielsen et al. High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study
IL171020A (en) Methods for diagnosing or predicting susceptibility to types of crohn's disease
Reller et al. Unsuspected leptospirosis is a cause of acute febrile illness in Nicaragua
Lei et al. Utility of in vitro interferon‐γ release assay in differential diagnosis between intestinal tuberculosis and C rohn's disease
Marciniak et al. Prevalence of Clostridium difficile colonization at admission to rehabilitation
ATE420360T1 (de) Verfahren zur unterscheidung von morbus crohn von ulzerativer colitis und anderen magen-darm- erkrankungen durch nachweis des vorhandenseins von fäkalen antikörpern gegen saccharomyces cerevisiae
Kabeer et al. Interferon gamma and interferon gamma inducible protein-10 in detecting tuberculosis infection
Miraglia A review of the centers for disease control and prevention’s guidelines for the clinical laboratory diagnosis of lyme disease
Yang et al. A novel one-step Helicobacter pylori saliva antigen test
Hyvönen et al. High prevalence of neurological sequelae and multiple chemical sensitivity among occupants of a Finnish police station damaged by dampness microbiota
Zhou et al. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China
Chan et al. Predictors of positive stool culture in adult patients with acute infectious diarrhea
Paranaguá‐Vezozzo et al. Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission
Gong et al. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test
Darton et al. Assessment and translation of the antibody-in-lymphocyte supernatant (ALS) assay to improve the diagnosis of enteric fever in two controlled human infection models and an endemic area of Nepal
Kim et al. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course
Xu et al. Pet ownership in utero and in childhood decreases the effects of environmental tobacco smoke exposure on hypertension in children: a large population based cohort study
Agan et al. Wastewater as a back door to serology?
Xia et al. A McAb-based direct competitive ELISA to detect O: 9 Salmonella infection in chicken
Taylor et al. Evaluation of serum Aspergillus‐specific immunoglobulin a by indirect ELISA for diagnosis of feline upper respiratory tract aspergillosis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties